Deciphera is seeking an experienced and highly motivated Associate Director, Commercial Training to lead the strategy, design, and execution of training programs that enable the success of the commercial organization in support of the anticipated launch of tirabrutinib, a highly potent and selective Bruton tyrosine kinase (BTK) inhibitor being advanced for patients with relapsed or refractory primary central nervous system lymphoma (R/R PCNSL). PCNSL is a rare and aggressive extra-nodal non-Hodgkin lymphoma with significant unmet need, and tirabrutinib represents an important potential new treatment option for patients facing limited therapeutic choices. The Associate Director, Commercial Training will play a key role in ensuring field readiness by building capabilities across disease state knowledge, product expertise, customer insights, market access dynamics, and selling skills. This individual will partner closely with Sales, Marketing, Medical Affairs, Market Access, Sales Operations, and other cross-functional stakeholders to deliver impactful training programs that support launch readiness, commercialization in a new disease area, and compliant customer engagement. The role also requires the ability to translate brand strategy and clinical data into practical learning experiences, identify capability gaps, and continuously enhance training effectiveness based on field insights and business needs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director